RGEN
USDRepligen Corporation Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$149.060
Máximo
$151.250
Mínimo
$146.000
Volume
0.61M
Fundamentos da empresa
Capitalização de mercado
8.3B
Setor
Medical Instruments & Supplies
País
United States
Estatísticas de negociação
Volume médio
0.92M
Bolsa de valores
NMS
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Repligen Corporation to Present at Upcoming November Conferences
WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending five upcoming
Canaccord Genuity Maintains Hold on Repligen, Raises Price Target to $165
Canaccord Genuity analyst Kyle Mikson maintains Repligen with a Hold and raises the price target from $150 to $165.
Barclays Maintains Overweight on Repligen, Raises Price Target to $175
Barclays analyst Luke Sergott maintains Repligen with a Overweight and raises the price target from $160 to $175.
Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
Revenue of $189 million, year-over-year increase of 22% as reported and 18% organic with double-digit reported growth across all franchisesOrders increased sequentially and greater than 20% year-over-yearIncreasing
Repligen to Report Third Quarter 2025 Financial Results
WALTHAM, Mass., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2025 financial results on Tuesday, October 28, 2025. The Company will
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.